| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $28,978,763 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 002 | 13 | NIH | 6/12/2025 | $38,385 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 001 | 13 | NIH | 6/10/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 000 | 13 | NIH | 1/15/2025 | $493,533 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01MH085927 | Synaptic function of BK channel-interacting proteins | 000 | 14 | NIH | 12/31/2024 | $468,965 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM156397 | UBIQUITIN-PROTEASOME PATHWAY in HUMAN DISEASE | 000 | 1 | NIH | 1/24/2025 | $528,129 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS131661 | Transient Receptor Potential Melastatin 2 (TRPM2) in Ischemic Stroke | 000 | 2 | NIH | 11/22/2024 | $406,904 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31HL178225 | TRPM7-mediated macrophage signaling in atherosclerosis | 001 | 1 | NIH | 12/20/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F31HL178225 | TRPM7-mediated macrophage signaling in atherosclerosis | 000 | 1 | NIH | 12/20/2024 | $45,122 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK132059 | Importance of cell-matrix interactions in kidney repair after acute kidney injury | 000 | 3 | NIH | 1/2/2025 | $438,257 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL177653 | Pathogenicity and pathophysiology assessments of sarcomere gene variants identified in the clinic | 000 | 1 | NIH | 12/13/2024 | $615,006 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 000 | 4 | NIH | 3/27/2025 | $236,206 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 2 | NIH | 1/14/2025 | $677,618 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 002 | 3 | NIH | 6/5/2025 | $55,259 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 001 | 3 | NIH | 12/16/2024 | $497,336 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R34MH129410 | Enhancing the Capacity of Pediatric Primary Care Providers: A Pilot Trial of Anxiety Action Plan | 000 | 3 | NIH | 12/19/2024 | $210,089 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 001 | 4 | NIH | 5/15/2025 | $30,149 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 000 | 3 | NIH | 1/9/2025 | $455,135 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 4 | NIH | 11/1/2024 | $387,625 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EY035976 | Targeting Corneal Schwann cells to counteract against toxin injury | 000 | 2 | NIH | 5/15/2025 | $249,750 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS133112 | Meningeal ectopic lymphoid tissues (mELTs): Composition, organization and expression revealed by imaging and in situ transcriptomics | 000 | 2 | NIH | 3/26/2025 | $439,761 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HD112424 | Dysregulation of Endometrial Invasibility Proximal to Uterine Scar as a Mechanism of Placenta Accreta | 000 | 2 | NIH | 4/9/2025 | $483,746 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01GM144379 | The regulation of phosphoprotein phosphatases in the nucleus | 000 | 3 | NIH | 4/17/2025 | $362,972 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK134475 | Novel mechanisms of kidney inflammation and fibrosis | 000 | 3 | NIH | 12/18/2024 | $471,240 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL165220 | Establishing and reversing the functional consequences of Titin truncation mutations | 000 | 4 | NIH | 6/12/2025 | $529,054 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30HL168980 | Predicting Cardiovascular Outcomes Using Diabetes-Induced Transcriptomic Networks | 000 | 3 | NIH | 5/29/2025 | $57,538 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK129431 | Role of FGF23 in Bone, Kidney, Blood, Crosstalk in Sickle Cell Disease Mice | 000 | 4 | NIH | 1/22/2025 | $498,828 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084284 | Cellular Therapy for Osteogenesis Imperfecta | 000 | 1 | NIH | 5/1/2025 | $386,481 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR080131 | The role of Dot1L activity in chondrogenic differentiation | 000 | 4 | NIH | 6/12/2025 | $432,936 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081659 | Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins | 000 | 4 | NIH | 5/19/2025 | $607,748 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA245514 | The selective advantage of mismatch repair loss in colonic stem cells | 001 | 5 | NIH | 5/27/2025 | $40,172 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA245514 | The selective advantage of mismatch repair loss in colonic stem cells | 000 | 5 | NIH | 4/4/2025 | $361,559 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM140631 | The Biology of Motile Cilia | 001 | 5 | NIH | 4/21/2025 | $749,898 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS120556 | Combinatorial function of Foxp1/2/4 in Purkinje cell diversification and cerebellar development | 000 | 5 | NIH | 3/26/2025 | $492,295 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR078149 | Mechanisms and Treatment of Hajdu Cheney Syndrome | 001 | 5 | NIH | 5/6/2025 | $25,256 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR078149 | Mechanisms and Treatment of Hajdu Cheney Syndrome | 000 | 5 | NIH | 4/18/2025 | $324,720 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | P30AG067988 | Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional) | 000 | 5 | NIH | 6/20/2025 | $1,333,352 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DA051671 | Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults | 000 | 4 | NIH | 4/1/2025 | $698,002 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA252045 | Microbiota, Metabolites, and Colon Neoplasia | 000 | 5 | NIH | 4/4/2025 | $517,782 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM133600 | Repetitive sequences drive genome variation and plasticity | 002 | 6 | NIH | 4/30/2025 | $16 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI158435 | Structural and mechanistic elucidation of non-canonical inflammasome signaling | 000 | 5 | NIH | 2/12/2025 | $397,700 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30AG081134 | The role of beta-secretase 1 (BACE1) in modulating excitatory synaptic and circuit function and behavior | 001 | 3 | NIH | 6/23/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30AG081134 | The role of beta-secretase 1 (BACE1) in modulating excitatory synaptic and circuit function and behavior | 000 | 3 | NIH | 3/12/2025 | $53,974 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 001 | 2 | NIH | 5/22/2025 | $48,268 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 000 | 2 | NIH | 3/3/2025 | $434,429 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI150919 | The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing | 000 | 5 | NIH | 2/13/2025 | $397,700 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30DK130582 | Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response | 001 | 4 | NIH | 6/9/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | F30DK130582 | Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response | 000 | 4 | NIH | 3/4/2025 | $53,974 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL150362 | RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity | 000 | 5 | NIH | 2/27/2025 | $490,600 |
| | 2025 | 2025 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21EB037174 | In situ formed microneedle-like depots for spatiotemporally controlled drug delivery | 000 | 1 | NIH | 6/25/2025 | $208,125 |
|
